Dasatinib for the treatment of acute lymphoblastic leukaemia
- Status:
- Discontinued
- Technology type:
- Medicine
- Decision:
- Prioritised
- Process:
- TA
- ID number:
- 386
- Referral date:
- 01 June 2008
- Topic area
- Cancer
Provisional Schedule
- Closing date for invited submissions / evidence submission::
- TBC
- 1st appraisal committee meeting::
- TBC
Project Team
- Communications manager:
- TBC
- Executive Lead:
- TBC
- Project manager:
- TBC
- Technical Lead:
- TBC
Email enquiries
If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 23 December 2008 | Please note that this topic has been removed from the technology appraisals work programme. |
For further information on our processes and methods, please see our CHTE processes and methods manual